http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20130102814-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e71c17ec6e47dd48a6dd4f316d2c0fb5 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4375 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375 |
| filingDate | 2012-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d84d4aeea5fedf2be620577e50a37a1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df6af99f1ba234a4923a4d4f1cbdaaa1 |
| publicationDate | 2013-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20130102814-A |
| titleOfInvention | Pharmaceutical composition for inhibiting angiogenesis comprising an imidazopyridine derivative having a PI3-kinase inhibitory activity as an active ingredient |
| abstract | The present invention provides N- (5- (3- (5-methyl-1,2,4-oxadiazol-3-yl) imidazo [1,2-a] pyridine-6- having PI3-kinase inhibitory activity. The present invention relates to a pharmaceutical composition for inhibiting angiogenesis, comprising: 1) pyridin-3-yl) benzenesulfonamide as an active ingredient. N- (5- (3- (5-methyl-1,2,4-oxadiazol-3-yl) imidazo [1,2-a] pyridin-6-yl) pyridine-3- according to the present invention (1) Benzenesulfonamide inhibits the production of CD34, VEGF and vascular endothelial cells, and is excellent in inhibiting angiogenesis. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019202826-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108721621-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10947225-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108721621-B |
| priorityDate | 2012-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 69.